Sven Dethlefs, EVP, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 119,310 shares at $9.89 ($1.2M) on 2023-02-28, disclosed to the SEC on 2023-03-02.
Seasonal sale ($1.2M) by EVP, North America Commercial — this insider has traded TEVA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.89 | 17,346 | $172K | 14.5% |
| 2 | $9.89 | 17,346 | $172K | 14.5% |
| 3 | $9.89 | 42,309 | $418K | 35.5% |
| 4 | $9.89 | 42,309 | $418K | 35.5% |
| Total | $9.89 avg | 119,310 | $1.2M | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $40K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $37K | — | Filing → |
| TEVA | SELL | 2021-03-08 | $127K | — | Filing → |